Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Natale Daniele Calandruccio"'
Autor:
Maria Teresa Di Martino, Mariamena Arbitrio, Daniele Caracciolo, Alessia Cordua, Onofrio Cuomo, Katia Grillone, Caterina Riillo, Giulio Caridà, Francesca Scionti, Caterina Labanca, Caterina Romeo, Maria Anna Siciliano, Maria D'Apolito, Cristina Napoli, Martina Montesano, Valentina Farenza, Valentina Uppolo, Michele Tafuni, Federica Falcone, Giuseppe D'Aquino, Natale Daniele Calandruccio, Francesco Luciano, Licia Pensabene, Pierosandro Tagliaferri, Pierfrancesco Tassone
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 27, Iss , Pp 1191-1224 (2022)
Among deregulated microRNAs (miRs) in human malignancies, miR-221 has been widely investigated for its oncogenic role and as a promising biomarker. Moreover, recent evidence suggests miR-221 as a fine-tuner of chronic liver injury and inflammation-re
Externí odkaz:
https://doaj.org/article/3c736b7269e24e3894170eed8e9340d9
Autor:
Antonella Fameli, Valerio Nardone, Mojtaba Shekarkar Azgomi, Giovanna Bianco, Claudia Gandolfo, Bianca Maria Oliva, Marika Monoriti, Rita Emilena Saladino, Antonella Falzea, Caterina Romeo, Natale Daniele Calandruccio, Domenico Azzarello, Rocco Giannicola, Luigi Pirtoli, Antonio Giordano, Pierfrancesco Tassone, Pierosandro Tagliaferri, Maria Grazia Cusi, Luciano Mutti, Cirino Botta, Pierpaolo Correale
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Peripheral immune-checkpoint blockade with mAbs to programmed cell death receptor-1 (PD-1) (either nivolumab or pembrolizumab) or PD-Ligand-1 (PD-L1) (atezolizumab, durvalumab, or avelumab) alone or in combination with doublet chemotherapy represents
Externí odkaz:
https://doaj.org/article/7c83e17e42a94c91add14fbda6384ccb
Autor:
Pierpaolo Correale, Rita Emilena Saladino, Diana Giannarelli, Andrea Sergi, Maria Antonietta Mazzei, Giovanna Bianco, Rocco Giannicola, Eleonora Iuliano, Iris Maria Forte, Natale Daniele Calandruccio, Antonia Consuelo Falzea, Alessandra Strangio, Valerio Nardone, Pierpaolo Pastina, Paolo Tini, Amalia Luce, Michele Caraglia, Daniele Caracciolo, Luciano Mutti, Pierfrancesco Tassone, Luigi Pirtoli, Antonio Giordano, Pierosandro Tagliaferri
Publikováno v:
Cells, Vol 9, Iss 9, p 1964 (2020)
Tumor-infiltrating T cell rescue by programmed cell death receptor-1 (PD-1)/PD-1 ligand-1 (PD-L1) immune checkpoint blockade is a recommended treatment for malignant diseases, including metastatic non-small-cell lung cancer (mNSCLC), malignant melano
Externí odkaz:
https://doaj.org/article/d23b3e92387b474e869261944ae728ba
Autor:
M. Reni, E. Giommoni, F. Bergamo, M. Milella, L. Cavanna, M.C. Di Marco, M. Spada, S. Cordio, G. Aprile, G.G. Cardellino, E. Maiello, I. Bernardini, M. Ghidini, S. Bozzarelli, M. Macchini, G. Orsi, I. De Simone, Er. Rulli, L. Porcu, V. Torri, C. Pinto, Michele Reni, Marina Macchini, Giulia Orsi, Umberto Peretti, Mariamaddalena Valente, Elisa Giommoni, Lorenzo Antonuzzo, Francesco Di Costanzo, Francesca Bergamo, Vittorina Zagonel, Sara Lonardi, Federica Buggin, Michele Milella, Silvia Palmerio, Luigi Cavanna, Camilla Di Nunzio, Maria Cristina Di Marco, Elisa Grassi, Massimiliano Spada, Marco Messina, Stefano Cordio, Francesco Avola, Giuseppe Aprile, Salvatore Pagano, Francesca Simionato, Giovanni Gerardo Cardellino, Federica Majer, Evaristo Maiello, Tiziana Pia Latiano, Cinzia Chiarazzo, Fabrizio Artioli, Giorgia Razzini, Antonella Pasqualini, Michele Ghidini, Elisa Binda, Silvia Lazzarelli, Silvia Bozzarelli, Simona Sala, Gabriele Luppi, Elisa Pettorelli, Andrea Spallanzani, Giovanni Vicario, Flavia Salmaso, Marco Basso, Nicola Silvestris, Sabina Del Curatolo, Fable Zustovich, Francesca Bongiovanni, Ciro Longobardi, Ilenia Sandi, Caterina Fontanella, Silvia Montelatici, Monica Giordano, Giovanna Luchena, Micol Gilardoni, Emiliano Tamburini, Britt Rudnas, Barbara Venturini, Barbara Merelli, Giorgia Negrini, Elio Maria Vici, Alessandra Marabese, Cristina Garetto, Paola Curcio, Saverio Cinieri, Margherita Cinefra, Pasqualinda Ferrara, Maurizio Cantore, Patrizia Morselli, Guglielmo Fumi, Agnese Isidori, Giovanni Ciccarese, Giovanni Luca Paolo Frassineti, Flavia Pagan, Vanja Vaccaro, Chiara Spoto, Marianna Ferrara, Carlo Garufi, Marta Caporale, Enrico Vasile, Francesca Salani, Elisa Barone, Rossana Berardi, Azzurra Onofri, Zelmira Ballatore, Alessandra Lucarelli, Alessandra Barucca, Amedeo Pancotti, Teresa Scipioni, Katia Bencardino, Giovanna Marrapese, Laura Idotta, Fausto Petrelli, Veronica Lonati, Anna Ceribelli, Angelo Giuli, Cristina Zannori, Maria Bassanelli, Andrea Mambrini, Laura Ginocchi, Massimo Orlandi, Luigi Celio, Monica Niger, Lavinia Biamonte, Stefano Tamberi, Alessandra Piancastelli, Giorgio Papiani, Irene Valli, Paolo Allione, Maria Giovanna Boe, Mario Scartozzi, Eleonora Lai, Annagrazia Pireddu, Pina Ziranu, Laura Demurtas, Marco Puzzoni, Stefano Mariani, Andrea Pretta, Nicole Liscia, Clementina Savastano, Valentina Malaspina, Giuseppe Tonini, Teresa Grassani, Barbara Barco, Tagliaferri Pierosandro, Domenico Ciliberto, Antonella Ierardi, Natale Daniele Calandruccio, Vincenzo Minotti, Roberta Matocci, Valter Torri, Luca Porcu, Erica Rulli, Irene De Simone, Luciano Carlucci, Eliana Rulli, Davide Poli, Paola Tonto, Francesca Scellato, Carmine Pinto
Background: Information about the adherence to scientific societies guidelines in the ‘real-world’ therapeutic management of oncological patients are lacking. This multicenter, prospective survey was aimed to improve the knowledge relative to 201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f827f8705c922ff764aa383826811530
https://hdl.handle.net/11585/919206
https://hdl.handle.net/11585/919206
Autor:
Giulio Caridà, Giulia Pelaia, Domenico Ciliberto, Nicoletta Staropoli, Maria Anna Siciliano, Natale Daniele Calandruccio, Daniele Caracciolo, Caterina Riillo, Rosa Toscano, Pierosandro Tagliaferri, Pierfrancesco Tassone, Marco Rossi
Background. Chronic Lymphocytic Leukemia (CLL) is the most common adult leukemia. IgVh unmutated CLL without 17p del/p53 aberrations (UN-only CLL) still carry a poorer prognosis as compared to IgVh mutated (MU-only) cases. The best front line and seq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::320cf8b34895ac3538e1146af4eff361
https://doi.org/10.21203/rs.3.rs-1494779/v1
https://doi.org/10.21203/rs.3.rs-1494779/v1
Autor:
Roberto Maisano, Giovanna Orizzonte, Giorgio Restifo, Pierpaolo Correale, Michele Caraglia, Vincenzo Dattola, Cirino Botta, Rita Agostino, Rita Emilena Saladino, Domenico Mazzacuva, Rocco Giannicola, Antonia Consuelo Falzea, Natale Daniele Calandruccio, Antonino Mafodda, Umberto Aguglia, Giovanna Bianco, Eleonora Iuliano, Vittoria Cianci
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 6246, p 6246 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Pembrolizumab (mAb to PD-1) has been recently approved for the therapy of pretreated urothelial cancer. Despite the efficacy, it is often accompanied by unpredictable and sometime severe immune-related (ir) adverse events (AEs). Here, we report the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d5f1730fa5ddbbe610ba6d945569661
http://hdl.handle.net/11591/462420
http://hdl.handle.net/11591/462420
Autor:
Antonia Consuelo Falzea, Amalia Luce, Maria Antonietta Mazzei, Giovanna Bianco, Rocco Giannicola, Eleonora Iuliano, Iris Maria Forte, Daniele Caracciolo, Luigi Pirtoli, Pierosandro Tagliaferri, Alessandra Strangio, Michele Caraglia, Rita Emilena Saladino, Paolo Tini, Pierpaolo Pastina, Antonio Giordano, Pierpaolo Correale, Andrea Sergi, Valerio Nardone, Diana Giannarelli, Pierfrancesco Tassone, Natale Daniele Calandruccio, Luciano Mutti
Publikováno v:
Cells
Volume 9
Issue 9
Cells, Vol 9, Iss 1964, p 1964 (2020)
Volume 9
Issue 9
Cells, Vol 9, Iss 1964, p 1964 (2020)
Tumor-infiltrating T cell rescue by programmed cell death receptor-1 (PD-1)/PD-1 ligand-1 (PD-L1) immune checkpoint blockade is a recommended treatment for malignant diseases, including metastatic non-small-cell lung cancer (mNSCLC), malignant melano
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bc9c929bb077dbc57de3cfcdd247b02
http://europepmc.org/articles/PMC7564884
http://europepmc.org/articles/PMC7564884
Autor:
Eleonora Iuliano, Andrea Sergi, Pierpaolo Correale, Giovanna Bianco, Amalia Luce, Alessia Stranges, Maria Antonietta Mazzei, Rita Emilena Saladino, Pierpaolo Pastina, Pierfrancesco Tassone, M. Altomonte, Rocco Giannicola, Paolo Tini, Natale Daniele Calandruccio, Pierosandro Tagliaferri, Michele Caraglia, Daniele Caracciolo, Luigi Pirtoli, Valerio Nardone, Diana Giannarelli
Publikováno v:
Journal of Clinical Oncology. 38:e15094-e15094
e15094 Background: Tumor infiltrating CTL-rescue by PD-1/PDL1 immune-checkpoint blockade is a recommended treatment for several malignancies including non-small-cell-lung-cancer (NSCLC), malignant melanoma, head and neck, kidney, and urothelial cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::158950d7652285895704d36e3f1f82c9
https://doi.org/10.1200/jco.2020.38.15_suppl.e15094
https://doi.org/10.1200/jco.2020.38.15_suppl.e15094